Transcriptomics

Dataset Information

0

Selective inhibition of JAK1 with filgotinib reverses pathogenic processes in the DSS preclinical model for IBD


ABSTRACT: The pathogenesis of inflammatory bowel diseases (IBD) is associated with a dysregulated mucosal immune response. The signaling of several cytokines regulating this immune response is mediated by kinases of the JAK family, i.e. JAK1, JAK2, JAK3 and TYK2. Filgotinib is a JAK1-selective inhibitor with demonstrated efficacy in phase 2 trials in patients with rheumatoid arthritis (RA) and Crohn’s disease (CD). Here, we investigated the effects of filgotinib on the DSS (dextran sulfate sodium) mouse model

ORGANISM(S): Mus musculus

PROVIDER: GSE105417 | GEO | 2020/10/19

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2023-07-20 | PXD031384 | Pride
2016-07-20 | E-GEOD-84562 | biostudies-arrayexpress
2016-07-20 | GSE84562 | GEO
2022-01-25 | GSE148346 | GEO
| PRJNA415138 | ENA
| PRJNA624040 | ENA
2017-12-31 | GSE85745 | GEO
2012-06-27 | E-GEOD-37012 | biostudies-arrayexpress
2020-03-03 | GSE136757 | GEO
2011-03-14 | E-MEXP-2621 | biostudies-arrayexpress